Clinical Trials · NCT06896981

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

CompletedPhase 2/Phase 3Semaglutide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Enrollment
31
Start date
Jan 2025
Locations
1 site, Bangladesh
Primary endpoint
Weight
View Semaglutide compound reference